Optilume® urethral drug coated balloon

Author: imfn

August undefined, 2024

WebApr 12, 2024 · The Optilume Urethral Drug Coated Balloon technology simultaneously dilates and delivers an anti-proliferative medicine to the urethral stricture. During the Optilume procedure, The Optilume device expands the scar tissue surrounding the urethral stricture creating a dilation and micro-fissures across the affected area. This allows the … WebJul 29, 2024 · Treatment of stricture of the anterior urethra with optilume DCB Standard of care treatment of stricture of the anterior urethra using the Optilume Drug Coated Balloon. Outcome Measures Go to Primary Outcome Measures : Responder Rate at 12 Months [ Time Frame: 12 months ]

Optilume Drug-Coated Balloon for Urethral Strictures

WebOptilume in NHS Wales The first @PublicHealthW #Optilume procedures were performed in @BetsiCadwaladr by Mr. Christian Seipp and the Urology team in Wrexham… WebDec 13, 2024 · The FDA has approved the Optilume drug-coated balloon catheter system for the treatment of men with urethral strictures. 1 The approval was based on data from the ROBUST I and ROBUST 3 clinical trials. The ROBUST I pilot study (NCT03014726) enrolled and treated 53 patients with recurrent bulbar strictures ≤2 cm who had received 1 to 4 … church weekly bulletin

Optilume® drug-coated balloon dilation in complex female urethral …

WebOptilume (Urotronic) is a drug-coated balloon indicated for treating anterior urethral strictures. The technology combines balloon dilation, to expand or widen the strictured ... This is the first study of using a paclitaxel-coated balloon for urethral strictures. Optilume is intended to be used without predilation. However in this study ... WebFeb 28, 2024 · One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume ® Drug-Coated Balloon for Anterior Urethral Strictures. J Urol. 2024 Dec 2:101097JU0000000000002346. doi ... WebMar 1, 2024 · We describe the first Optilume® urethral drug-coated balloon dilation for female urethral stricture disease involving the sphincter. After six months follow-up the patient remains stricture free with full continence and complete bladder emptying. Keywords Drug-coated balloon dilation Urethral stricture Optilume Female urethral stricture 1. dfe early outcomes

Economic evaluation of Optilume, a drug‐coated balloon for …

Laborie

WebA Safe, Simple and Durable Treatment for Urethral Stricture Break the stricture cycle The Optilume® urethral drug-coated balloon was developed in response to severe patient and … WebApr 10, 2024 · Approval of the Optilume® Urethral Drug Coated Balloon. The device is used to treat patients with obstructive urinary symptoms associated with anterior urethral stricture. It is designed to be used in adult males for urethral strictures of less than or equal to 3 cm in length. Approval Order: Approval Order: Summary: Summary of Safety and ... church weekly count sheetWebOptilume is an outpatient procedure that only takes 15 minutes to complete at our offices. It provides near immediate and lasting relief for stricture symptoms, and has been proven to be successful in 75% of cases a year later 1. One-Year Safety and Efficacy Outcomes on a Novel Drug Coated Balloon (DCB) for Urethral Stricture Disease – The ... dfee building bulletin 88

"WebThe Optilume drug-coated balloon (DCB) is an effective alternative to traditional stricture treatments, offering minimally-invasive, immediate relief. Optilume works by preventing new scar tissue growth that often returns … " - Optilume® urethral drug coated balloon

Optilume® urethral drug coated balloon

WebApr 10, 2024 · PDF On Apr 10, 2024, Laura Kelly and others published Economic evaluation of Optilume, a drug‐coated balloon for recurrent anterior male urethral stricture Find, read and cite all the ... WebThe Optilume drug-coated balloon is an exciting innovation in urethral stricture treatment—giving patients and physicians an effective solution that can deliver Laborie Medical owns the global commercialization …

Did you know?

WebOptilume drug-coated balloon is a novel treatment for anterior urethral strictures in men. The procedure is done under flexible cystoscopy guidance and involves a combination of balloon dilatation of the urethral stricture and treating the dilated area with paclitaxel, a microtubule inhibitor. WebJan 5, 2024 · The technology. Optilume (Urotronic) is a drug-coated balloon indicated for treating anterior urethral strictures. The technology combines balloon dilation, to expand or widen the strictured area, with delivering an anti-proliferative drug (paclitaxel) to reduce stricture recurrence. Optilume is inserted under direct endoscopic vision (with or ...

WebFeb 28, 2024 · Elliott SP, Virasoro R, Estrella R, et al. MP56-06 The Optilume Drug Coated Balloon for Recurrent Anterior Urethral Strictures: ROBUST I Clinical Study 3-year follow up, N = 43. J Urol 2024;206(3S ... WebThis study investigates the safety and efficacy of the Optilume™ paclitaxel-coated balloon for the treatment of recurrent strictures. Methods: Men with recurrent bulbar strictures ≤2 cm with 1-4 prior endoscopic treatments were treated with the Optilume™ drug-coated balloon. Patients were evaluated within 14 days, three, six, 12, and 24 ...

WebDec 13, 2024 · The Optilume® drug-coated balloon technology provides a low cost, minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic ... WebNov 7, 2024 · Optilume’s paclitaxel-coated balloon technology combines mechanical dilation for immediate symptomatic relief with local drug delivery to maintain urethral patency. The technology was developed in response to patient and physician dissatisfaction with current endoscopic solutions for urethral strictures.

WebApr 10, 2024 · In conclusion, the findings of this analysis support the use of Optilume urethral drug-coated balloon as an alternative to the standard of care endoscopic management in the treatment of men with recurrent anterior male urethral stricture in England. This was shown in the base case scenario and in the results of the deterministic …

WebThe Optilume (Urotronic, Plymouth, MN, USA) drug-coated balloon, Figure 1, is a minimally invasive urethral stricture treatment developed in response to demand for improved … dfe early reading documentWebThe Optilume drug-coated balloon represents a step forward in the endoscopic management of urethral strictures. The drug-coated balloon may offer an intermediate step prior to … church weekly finance report dfe early reading july 2021WebMar 17, 2024 · The device uses a drug coated balloon to dilate the urethra at the site of the stricture. The balloon is coated on its outer surface with paclitaxel, which is then … dfe diversity and inclusion in schoolsWebApr 8, 2024 · The Optilume ® BPH Catheter System (Urotronic Inc., Plymouth, Minnesota, USA) is the first prostatic drug-coated balloon dilation system for the treatment of … church weekly bulletin templateWebThe Optilume drug-coated balloon represents a step forward in the endoscopic management of urethral strictures. The drug-coated balloon may offer an intermediate step prior to repeated dilations, urethrostomies, or urethroplasty. church weekly financial report templateWebOct 14, 2024 · “Optilume exhibited a significant improvement in [the primary] objective outcome at 6 months and subjective outcomes at 1-year post treatment compared to standard of care,” said Chee. “The novel drug-coated balloon may represent a breakthrough in the endoscopic management of recurrent anterior urethral stricture disease.” dfee building bulletins